Kiwi Wealth Investments Limited Partnership’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-47,500	Closed	-$5.81M	–	292
2021 Q3	$5.81M	Buy	+47,500	New	+$5.48M	0.3%	87
2020 Q4	–	Sell	-28,137	Closed	-$2.18M	–	299
2020 Q3	$2.18M	Buy	28,137 +2,219	+9%	+$189K	0.15%	166
2020 Q2	$2.89M	Buy	25,918 +2,277	+10%	+$198K	0.23%	114
2020 Q1	$1.7M	Buy	+23,641	New	+$2.02M	0.17%	132

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's KRTX Position: Q4 2021 in Review

Kiwi Wealth Investments Limited Partnership sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2021, closing a stake of 47,500 shares — an estimated $5.81M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in KRTX in Q1 2020 and held it in 4 quarters. The position peaked at $5.81M in Q3 2021. 171 funds tracked by Wall St. Rank hold KRTX as of Q4 2021.

Kiwi Wealth Investments Limited Partnership reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Kiwi Wealth Investments Limited Partnership sold 47,500 Karuna Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $5.81M.
Kiwi Wealth Investments Limited Partnership first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
Kiwi Wealth Investments Limited Partnership's Karuna Therapeutics, Inc. Common Stock position peaked at $5.81M in Q3 2021.
171 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q4 2021, filed 15 Feb 2022.